FDA Tightlipped On Status Of ‘SPF Determination’ Study, But Issue Is A Concern
This article is powered by The Rose Sheet
Executive Summary
FDA’s 2016 request for contractor services to perform SPF testing on US-marketed sunscreen products has come up in litigation challenging brands’ SPF claims. The agency told Rose Sheet the issue of accurately labeled SPFs is a concern, but declined to provide further update on what it characterized as a pending matter.
You may also be interested in...
What’s In A Name? Babyganics Settles False Advertising Allegations To Tune Of $2.2M
The SC Johnson brand can continue to use the name Babyganics as long as it specifies on product labeling which ingredients are organic, and which aren’t, per a pending class action settlement in New York’s Southern District. The company also has agreed to sunscreen batch testing for a three-year period to verify the authenticity of SPF claims.
SPF Fraud Cases Hard To Shake, Could Shine Light On FDA Protocol Problems
As SPF defendants’ dismissal motions continue to be shot down in federal courts, it increasingly seems that their SPF claims and the radically different test results alleged by plaintiffs will have to be subjected to rigorous analysis and expert opinion, undertakings that could shine light on inherent problems with FDA’s testing protocol rather than overt moves by companies to inflate the protective capacity of their products.
SPF Claims No More Reliable In 2018 Than Previous Years – Consumer Reports
The nonprofit publication’s 2018 sunscreen ratings and buying guide reflect its own SPF testing in which a third of sunscreens again underperformed dramatically compared with labeled SPFs. Low-scoring brands may face a new wave of false-advertising litigation, with many related suits still pending in federal and state courts.